$Emergent BioSolutions (EBS.US)$ It's a different story from...
It's a different story from stock prices falling overall
It's been rising steadily and is 11.2 dollars, but the analyst's evaluation and target value is 888, aren't you going to adjust it according to this target value? Will analysts change target values? You don't understand
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment